The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PEP503 (NBTXR3), a radioenhancer, in combination with concurrent chemoradiation (CCRT) in locally advanced or recurrent head and neck squamous cell carcinoma (HNSCC): Dose-finding of a phase 1b/2 trial.
 
Cheng-Hsu Wang
Consulting or Advisory Role - Taivex Therapeutics
 
K.S.Clifford Chao
No Relationships to Disclose
 
Ping-Tsung Chen
No Relationships to Disclose
 
Kun-Yun Yeh
No Relationships to Disclose
 
Yen-Chao Chen
No Relationships to Disclose
 
Yao-Liang Chen
No Relationships to Disclose
 
Shih-Wei Yang
No Relationships to Disclose
 
Tsung-Han Wu
No Relationships to Disclose
 
Pei-Hung Chang
No Relationships to Disclose
 
Chi-Kuang Young
No Relationships to Disclose
 
Din-Li Tsan
No Relationships to Disclose
 
Ming-Hsui Tsai
No Relationships to Disclose
 
Ching-Yun Hsieh
No Relationships to Disclose
 
Wen-Cheng Chen
No Relationships to Disclose
 
Yuan-Hsiung Tsai
No Relationships to Disclose
 
Cheng-Ming Hsu
No Relationships to Disclose
 
John W. C. Chang
No Relationships to Disclose
 
Wei-Che Yu
Employment - PharmaEngine
Stock and Other Ownership Interests - PharmaEngine
 
Bor-Nian Shen
Employment - PharmaEngine
Stock and Other Ownership Interests - PharmaEngine